Day: November 20, 2025

All amounts in U.S. dollars BROOKFIELD, NEWS, Nov. 19, 2025 (GLOBE NEWSWIRE) — Brookfield Infrastructure Corporation (NYSE: BIPC; TSX: BIPC) (“BIPC”) today announced that it has made the necessary Canadian and U.S. securities filings to enable an “at the market” equity issuance program (the “ATM Program”). Under the ATM Program, BIPC may, at its discretion, offer and sell up to $400 million (or the Canadian dollar equivalent) of class A exchangeable subordinate voting shares (the “BIPC Shares”) directly from treasury. These shares may be sold to the public from time to time at prevailing market prices through the Toronto Stock Exchange, the New York Stock Exchange or any other marketplace in Canada or the United States where BIPC Shares may be traded. As a result, sale prices of the BIPC Shares sold under the ATM Program, if any,...

HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the closing of its previously announced issuance and sale to an existing shareholder of 3,540,000 shares of its common stock and pre-funded warrants to purchase 8,570,203 shares of its common stock at a purchase price of $0.3303 per share or pre-funded warrant (less $0.00001 for each pre-funded warrant), in a registered direct offering priced at-the-market under Nasdaq rules. The pre-funded warrants are exercisable at any time at an exercise price of $0.00001 per share and do not expire. The...